XY.ai - About the company
XY.ai is an unfunded company based in Palo Alto (United States), founded in 2017. It operates as a Provides software for managing genetic and health data. XY.ai has not raised any funding yet. The company has 81 active competitors, including 16 that are funded. Its top competitors include companies like Unlearn, Ryght and Virtonomy.
Company Details
XY.ai provides a software solution to manage genetic, socio-demographic, and health data. It helps healthcare companies and medical professionals analyze massive data. It gives the exposome geosurveillance system to predict health, twin technology that enables new clinical trials by discovering each trial participant’s silicon clone and artificial intelligence system for enhancing biomedical knowledge.
Key Metrics
Founded Year
2017
Location
Palo Alto, United States
Stage
Unfunded
Ranked
10th among 81 active competitors
Employee Count
14 as on Aug 31, 2026
Sign up to download XY.ai's company profile
XY.ai's funding and investors
XY.ai has not raised any funding rounds yet.
XY.ai's founders and board of directors
Founder? Claim ProfileXY.ai's employee count trend
XY.ai has 14 employees as of Aug 26. Here is XY.ai's employee count trend over the years:
Uncover XY.ai's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
XY.ai's Competitors and alternates
Top competitors of XY.ai include Unlearn, Ryght and Virtonomy. Here is the list of Top 10 competitors of XY.ai, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Unlearn 2017, San Francisco (United States), Series C | Developer of an AI platform for clinical trial design and analysis | $135M | 63/100 | |
2nd |  Ryght 2023, Anaheim (United States), Series A | Generative AI platform focused on biopharma smart biomedical data | $7.25M | 54/100 | |
3rd | Provider of virtual patient simulation for medical device development | $9.69M | 53/100 | ||
4th | ELEM Biotech 2018, Barcelona (Spain), Seed | Provider of a simulation based platform for doctors | $2.27M | 44/100 | |
5th |  Verto Health 2017, Toronto (Canada), Seed | Provider of AI-based digital twin platform for population health management | $1.52M | 42/100 | |
6th |  Doctus Tech 2014, Costa Mesa (United States), Unfunded | Developer of an app for workflow management | - | - | 41/100 |
7th | Provider of digital twin-based precision therapy solution | $2.78M | 39/100 | ||
8th |  Adsilico 2022, London (United Kingdom), Seed | Provider of insilico trials using virtual patients to assess medical device safety | $4.56M | 38/100 | |
9th |  Precision Diagnosis Technology Series B | Provider of digital twin technology for precision medicine | $15.5M | 34/100 | |
10th |  XY.ai 2017, Palo Alto (United States), Unfunded | Provides software for managing genetic and health data | - | - | 34/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on XY.ai's competitors? Click here to see the top ones
XY.ai's Investments and acquisitions
XY.ai has made no investments or acquisitions yet.
Reports related to XY.ai
Here is the latest report on XY.ai's sector:
Are you a Founder ?
FAQs about XY.ai
Explore our recently published companies
- Una Home Care - Beverly Hills based, 2026 founded, Unfunded company
- Boooply - 2026 founded, Unfunded company
- Uaity - 2026 founded, Unfunded company
